Cargando…

Investigating the Metabolic Level of Endogenous and Exogenous Substances on the Intervention of Traditional Chinese Medicine Fuzheng Yiliu Decoction in a Rat Orthotopic Liver Cancer Model

BACKGROUND: Fuzheng Yiliu decoction (FZYLD), a Chinese formula consisting of four herbs, can be clinically used as an adjuvant therapy after surgery or palliative treatment for advanced liver cancer. METHODS: This study identified the endogenous and exogenous metabolites of FZYLD in rat serum to cha...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Hongcheng, Dai, Qiwen, Zeng, Maogui, Liu, Yingying, Du, Jian, Pang, Wensheng, Hu, Juan, Chen, Liwu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9492441/
https://www.ncbi.nlm.nih.gov/pubmed/36160035
http://dx.doi.org/10.2147/CMAR.S377621
_version_ 1784793482321199104
author Zhang, Hongcheng
Dai, Qiwen
Zeng, Maogui
Liu, Yingying
Du, Jian
Pang, Wensheng
Hu, Juan
Chen, Liwu
author_facet Zhang, Hongcheng
Dai, Qiwen
Zeng, Maogui
Liu, Yingying
Du, Jian
Pang, Wensheng
Hu, Juan
Chen, Liwu
author_sort Zhang, Hongcheng
collection PubMed
description BACKGROUND: Fuzheng Yiliu decoction (FZYLD), a Chinese formula consisting of four herbs, can be clinically used as an adjuvant therapy after surgery or palliative treatment for advanced liver cancer. METHODS: This study identified the endogenous and exogenous metabolites of FZYLD in rat serum to characterize the underlying mechanism of its antitumor activity, as well as relieving cancer-related weakness. An orthotopic transplantation rat model of HepG2 cells was established and administered with FZYLD by gastric perfusion for 14 days. Cardiopulmonary function and tail suspension test were used to evaluate the bodily weakness of hepatocellular carcinoma (HCC) rats. Tumor weight and size were measured to calculate inhibition ratios. Serum of different concentrations of FZYLD was used to culture the 2-[N-(7-nitrobenz-2-oxa-1, 3-diaxol-4-yl) amino]-2-deoxyglucose-labeled HepG2 cells. IC(50) value was measured using MTT assay. Endogenous and exogenous metabolites in rat serum were detected using nuclear magnetic resonance or LC-MS/MS spectroscopy. RESULTS: FZYLD improved cardiopulmonary function, decreased immobility time in tail suspension test, and yielded tumor inhibition ratios of up to 27%. Serum endogenous markers, such as lipoproteins (high- and low-density lipoproteins), glucose, and valine, and lactic acid metabolic disturbance were recovered, to some extent, in HCC rats. Exogenous metabolites, diosgenin, apigenin-7-O-acetyl-β-D-glucoside, calycosin-7-glucoside, calycosin, ganoderic-acid-A, formononetin, and methylnissolin, became detectable in the blood. FZYLD-containing serum substantially inhibited the proliferation of HepG2-cells. IC(50) value was found to be 24.31%. Further, we confirmed that FZYLD could revert energy and lipid metabolism disorders and that its constituents could be bioactive components that induce apoptosis in cancer cells. CONCLUSION: The present study explained the mechanism of the effect of FZYLD on body empty, fatigue, and low immunity in patients with cancer, offering an efficient way for research of natural compounds in traditional Chinese medicine.
format Online
Article
Text
id pubmed-9492441
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-94924412022-09-22 Investigating the Metabolic Level of Endogenous and Exogenous Substances on the Intervention of Traditional Chinese Medicine Fuzheng Yiliu Decoction in a Rat Orthotopic Liver Cancer Model Zhang, Hongcheng Dai, Qiwen Zeng, Maogui Liu, Yingying Du, Jian Pang, Wensheng Hu, Juan Chen, Liwu Cancer Manag Res Original Research BACKGROUND: Fuzheng Yiliu decoction (FZYLD), a Chinese formula consisting of four herbs, can be clinically used as an adjuvant therapy after surgery or palliative treatment for advanced liver cancer. METHODS: This study identified the endogenous and exogenous metabolites of FZYLD in rat serum to characterize the underlying mechanism of its antitumor activity, as well as relieving cancer-related weakness. An orthotopic transplantation rat model of HepG2 cells was established and administered with FZYLD by gastric perfusion for 14 days. Cardiopulmonary function and tail suspension test were used to evaluate the bodily weakness of hepatocellular carcinoma (HCC) rats. Tumor weight and size were measured to calculate inhibition ratios. Serum of different concentrations of FZYLD was used to culture the 2-[N-(7-nitrobenz-2-oxa-1, 3-diaxol-4-yl) amino]-2-deoxyglucose-labeled HepG2 cells. IC(50) value was measured using MTT assay. Endogenous and exogenous metabolites in rat serum were detected using nuclear magnetic resonance or LC-MS/MS spectroscopy. RESULTS: FZYLD improved cardiopulmonary function, decreased immobility time in tail suspension test, and yielded tumor inhibition ratios of up to 27%. Serum endogenous markers, such as lipoproteins (high- and low-density lipoproteins), glucose, and valine, and lactic acid metabolic disturbance were recovered, to some extent, in HCC rats. Exogenous metabolites, diosgenin, apigenin-7-O-acetyl-β-D-glucoside, calycosin-7-glucoside, calycosin, ganoderic-acid-A, formononetin, and methylnissolin, became detectable in the blood. FZYLD-containing serum substantially inhibited the proliferation of HepG2-cells. IC(50) value was found to be 24.31%. Further, we confirmed that FZYLD could revert energy and lipid metabolism disorders and that its constituents could be bioactive components that induce apoptosis in cancer cells. CONCLUSION: The present study explained the mechanism of the effect of FZYLD on body empty, fatigue, and low immunity in patients with cancer, offering an efficient way for research of natural compounds in traditional Chinese medicine. Dove 2022-09-17 /pmc/articles/PMC9492441/ /pubmed/36160035 http://dx.doi.org/10.2147/CMAR.S377621 Text en © 2022 Zhang et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Zhang, Hongcheng
Dai, Qiwen
Zeng, Maogui
Liu, Yingying
Du, Jian
Pang, Wensheng
Hu, Juan
Chen, Liwu
Investigating the Metabolic Level of Endogenous and Exogenous Substances on the Intervention of Traditional Chinese Medicine Fuzheng Yiliu Decoction in a Rat Orthotopic Liver Cancer Model
title Investigating the Metabolic Level of Endogenous and Exogenous Substances on the Intervention of Traditional Chinese Medicine Fuzheng Yiliu Decoction in a Rat Orthotopic Liver Cancer Model
title_full Investigating the Metabolic Level of Endogenous and Exogenous Substances on the Intervention of Traditional Chinese Medicine Fuzheng Yiliu Decoction in a Rat Orthotopic Liver Cancer Model
title_fullStr Investigating the Metabolic Level of Endogenous and Exogenous Substances on the Intervention of Traditional Chinese Medicine Fuzheng Yiliu Decoction in a Rat Orthotopic Liver Cancer Model
title_full_unstemmed Investigating the Metabolic Level of Endogenous and Exogenous Substances on the Intervention of Traditional Chinese Medicine Fuzheng Yiliu Decoction in a Rat Orthotopic Liver Cancer Model
title_short Investigating the Metabolic Level of Endogenous and Exogenous Substances on the Intervention of Traditional Chinese Medicine Fuzheng Yiliu Decoction in a Rat Orthotopic Liver Cancer Model
title_sort investigating the metabolic level of endogenous and exogenous substances on the intervention of traditional chinese medicine fuzheng yiliu decoction in a rat orthotopic liver cancer model
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9492441/
https://www.ncbi.nlm.nih.gov/pubmed/36160035
http://dx.doi.org/10.2147/CMAR.S377621
work_keys_str_mv AT zhanghongcheng investigatingthemetaboliclevelofendogenousandexogenoussubstancesontheinterventionoftraditionalchinesemedicinefuzhengyiliudecoctioninaratorthotopiclivercancermodel
AT daiqiwen investigatingthemetaboliclevelofendogenousandexogenoussubstancesontheinterventionoftraditionalchinesemedicinefuzhengyiliudecoctioninaratorthotopiclivercancermodel
AT zengmaogui investigatingthemetaboliclevelofendogenousandexogenoussubstancesontheinterventionoftraditionalchinesemedicinefuzhengyiliudecoctioninaratorthotopiclivercancermodel
AT liuyingying investigatingthemetaboliclevelofendogenousandexogenoussubstancesontheinterventionoftraditionalchinesemedicinefuzhengyiliudecoctioninaratorthotopiclivercancermodel
AT dujian investigatingthemetaboliclevelofendogenousandexogenoussubstancesontheinterventionoftraditionalchinesemedicinefuzhengyiliudecoctioninaratorthotopiclivercancermodel
AT pangwensheng investigatingthemetaboliclevelofendogenousandexogenoussubstancesontheinterventionoftraditionalchinesemedicinefuzhengyiliudecoctioninaratorthotopiclivercancermodel
AT hujuan investigatingthemetaboliclevelofendogenousandexogenoussubstancesontheinterventionoftraditionalchinesemedicinefuzhengyiliudecoctioninaratorthotopiclivercancermodel
AT chenliwu investigatingthemetaboliclevelofendogenousandexogenoussubstancesontheinterventionoftraditionalchinesemedicinefuzhengyiliudecoctioninaratorthotopiclivercancermodel